Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
[4] Clinical trials [edit] Retatrutide has been studied in a phase 2 trial involving adults without diabetes but with obesity or preobesity (overweight)
No significant toxicity indicators reported during the preclinical trials
Both the 3-month and 6-month plans qualify for $50 off the first month with code policy-lab-50
| Target Concentration | BAC Water to Add | Dose per 10 units on syringe | |---------------------|-----------------|------------------------------| | 5mg/ml | 2.0ml | 0.5mg | | 10mg/ml | 1.0ml | 1.0mg | **Best for:** Patients on 1-2mg weekly doses during titration weeks 1-8
Attend expert-led Workshops (in person or virtual) and connect with others on similar journeys
Compounded Tirzepatide from PlexusDx: Access and Support Throughout Side Effects PlexusDx compounds tirzepatide through licensed 503A pharmacies, making the medication accessible across all 50 states without insurance or membership requirements
